Pelvic Girdle Pain Symptom Severity in Pregnant Women With Gestational Diabetes Mellitus
- Conditions
- Pelvic Girdle PainPregnant WomenGestational Diabetes
- Interventions
- Other: Evaluation of painDiagnostic Test: Evaluation of pelvic girdle pain diagnostic testsOther: Evaluation of activity limitation
- Registration Number
- NCT05403437
- Lead Sponsor
- Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
- Brief Summary
Pelvic girdle pain (PGP), which is a common musculoskeletal problem of pregnancy, and gestational diabetes mellitus (GDM), which is diagnosed at the end of the second trimester and at the beginning of the third trimester, occur in a parallel time period. The addition of hyperglycemia to the physiological changes in pregnancy stimulates a new series of cycles and contributes to inflammation, and it is predicted that the presence of GDM may trigger the pain intensity of PGP. Therefore, the aim of this study is to investigate the effect of GDM on PGP symptom severity (pain).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 155
- Pregnant women (with PGP) diagnosed with GDM in the 2nd and 3rd trimesters, whose treatment process (diet/insulin) for insulin regulation have been started.
- Pregnant women (with PGP) diagnosed with GDM in the 2nd and 3rd trimesters, whose treatment process (diet/insulin) for insulin regulation have not been started
- Pregnant women (with PGP) who were not diagnosed with GDM in the 2nd and 3rd trimesters
- Pre-pregnancy Diabetes Mellitus
- Presence of an orthopedic or neurological problem that may cause musculoskeletal disorders and deviations from normal biomechanical alignment
- Presence of connective tissue disease
- Definition of chronic low back-pelvic region pain (lasting for more than 3 months and pain severity >4 according to VAS) before pregnancy
- History of spine, pelvis, or lower extremity surgery or fracture in the past 6 months
- History of pelvic fracture
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Group 2: Pregnant women with PGP and diagnosed with GDM Evaluation of pain Pregnant women with PGP who were diagnosed with Gestational Diabetes Mellitus (GDM) according to routine control examinations and whose treatment has been already started for diabetes Group 2: Pregnant women with PGP and diagnosed with GDM Evaluation of pelvic girdle pain diagnostic tests Pregnant women with PGP who were diagnosed with Gestational Diabetes Mellitus (GDM) according to routine control examinations and whose treatment has been already started for diabetes Group 3: Pregnant women with PGP Evaluation of pain Pregnant women with PGP who were not diagnosed with GDM according to routine control examinations Group 1: Pregnant women with PGP and newly diagnosed with GDM Evaluation of pelvic girdle pain diagnostic tests Pregnant women with PGP who were newly diagnosed with Gestational Diabetes Mellitus (GDM) according to routine control examinations and whose treatment for diabetes was not started Group 1: Pregnant women with PGP and newly diagnosed with GDM Evaluation of activity limitation Pregnant women with PGP who were newly diagnosed with Gestational Diabetes Mellitus (GDM) according to routine control examinations and whose treatment for diabetes was not started Group 2: Pregnant women with PGP and diagnosed with GDM Evaluation of activity limitation Pregnant women with PGP who were diagnosed with Gestational Diabetes Mellitus (GDM) according to routine control examinations and whose treatment has been already started for diabetes Group 1: Pregnant women with PGP and newly diagnosed with GDM Evaluation of pain Pregnant women with PGP who were newly diagnosed with Gestational Diabetes Mellitus (GDM) according to routine control examinations and whose treatment for diabetes was not started Group 3: Pregnant women with PGP Evaluation of pelvic girdle pain diagnostic tests Pregnant women with PGP who were not diagnosed with GDM according to routine control examinations
- Primary Outcome Measures
Name Time Method Determining of painful areas Baseline (Current) Marking painful areas on the body chart
Evaluation of pain Baseline (Current) Pain will be evaluated with Visual Analog Scale (VAS). The VAS is scaled between 0-10 points (0: no pain, 10: most severe pain).
Application of PGP diagnostic tests Baseline Pelvic Girdle Pain diagnostic tests will be applied. No score defined for test.
Evaluation of PGP severity Baseline The severity of the pain that occurs in positive tests will be evaluated with VAS. The VAS is scaled between 0-10 points (0: no pain, 10: most severe pain).
- Secondary Outcome Measures
Name Time Method Pelvic Girdle Questionnaire Baseline Activity limitation will be evaluated Pelvic Girdle Questionnaire
Evaluation of Body Weight Baseline Measuring of the Body Weight
Evaluation of Body Mass Index (BMI) Baseline BMI (kg/m2) will be calculated as person's weight in kilograms divided by the square of height in meters.
Trial Locations
- Locations (1)
İstanbul Medeniyet University
🇹🇷İstanbul, Turkey